Antiviral effects of 6-chloro-2',3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 1, 1998, Pages 85-92

  Fujii, Y ^a,b   Mukai, R ^b   Akari, H ^b,c   Machida, M ^a   Mori, K ^b   Takasaka, M ^b   Kojima, E ^a   Murakami, K ^a   Yoshikawa, Y ^b  

^a NIPPON PAPER INDUSTRIES CO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

6 Chloro 2,3' dideoxyguanosine; Acute SIV infection; Anti HIV agent; Rhesus monkeys

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 6 CHLORO 2',3' DIDEOXYGUANOSINE; ANTIVIRUS AGENT; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFECT; DRUG TOXICITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELL LINE; COCULTURE TECHNIQUES; CYTOPATHOGENIC EFFECT, VIRAL; DIDEOXYNUCLEOSIDES; FEMALE; MACACA MULATTA; MALE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; VIRUS REPLICATION;

EID: 0031984776     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Akari H, Mori K, Terao K, Otani I, Fukasawa M, Mukai R & Yoshikawa Y (1996) In vitro immortalization of Old World monkey T lymphocytes with herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses. Virology 218:382-388.
2. Bottiger D, Ljungdahl-Ståhle E & Öberg B (1991) Treatment of acute SIV infection in cynomolgus monkeys with 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxythymidine (d4T). Antiviral Chemistry & Chemotherapy 2:357-361.
3. Fazely F, Haseltine WA, Rodger RF & Ruprecht RM (1991) Postexposure chemo-prophylaxis with ZDV or ZDV combined with interferon-α: failure after inoculating rhesus monkeys with a high dose of SIV. Journal of Acquired Immune Deficiency Syndromes 4:1093-1097.
4. Fujii Y, Mukai R, Murayama Y, Akari H, Machida M, Mori K, Takasaka M, Murakami K & Yoshikawa Y (1997) Efficacy of 6-chloro-2′,3′-dideoxyguanosine (6-Cl-ddG) on an ARC/AIDS rhesus macaque (Macaca mulatta) infected with simian immunodeficiency virus. Experimental Animals 46:83-87.
5. Hawkins ME, Mitsuya H, McCully CM, Godwin KS, Murakami K, Poplack DG & Balis FM (1995) Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys. Antimicrobial Agents & Chemotherapy 39:1259-1264.
6. Honjo S, Narita T, Kobayashi R, Hiyaoka A, Fujimoto K, Takasaka M, Sakakibara I, Mukai R, Ishikawa K, Ohta Y & Hayami M (1990) Experimental infection of African green monkeys and cynomolgus monkeys with a SIVagm strain isolated from a healthy African green monkey. Journal of Medical Primatology 19:9-20.
7. Kestler HW, Kodama T, Ringler DJ, Marthas M, Pedersen N, Lackner A, Regier DA, Sehgal P, Daniel MD, King N & Desrosiers RC (1990) Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
8. Lundgren B, Ljungdahl-Ståhle E, Böttiger D, Benthin R, Hedström K-G, Norrby E, Putkonen P, Wahren B & Öberg B (1990) Acute infection of cynomolgus monkeys with simian immunodeficiency virus (SIVsm) as a model to evaluate antiviral compounds. Effects of 3′-azido,3′-deoxythymidine, foscarnet and 2′,3′-dideoxycytidine. Antiviral Chemistry & Chemotherapy 1:299-306.
9. McClure HM, Anderson DC, Ansari AA, Fultz PN, Klumpp SA & Schinazi RF (1990) Nonhuman primate models for evaluation of AIDS therapy. Annals of the New York Academy of Science 616:287-298.
10. Morgan ME, Chi S-C, Murakami K, Mitsuya H & Anderson BD (1992) Central nervous system targeting of 2′,3′-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs. Antimicrobial Agents & Chemotherapy 36:2156-2165.
11. Mori K, Ringler DJ & Desrosiers RC (1993) Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. Journal of Virology 67:2807-2814.
12. Murakami K, Shirasaka T, Yoshioka H, Kojima E, Aoki S, Ford H, Driscoll JS, Kelley JA & Mitsuya H (1991) Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2′,3′-dideoxypurine nucleosides. Journal of Medicinal Chemistry 34:1606-1612.
13. Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, Wolters P, Brouwers P, Jarosinski P, Rubin M, Broder S, Yarchoan R, Brunetti A, Maha M, Nusinoff-Lehrman S & Poplack DG (1988) Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. New England Journal of Medicine 319:889-896.
14. Price RW, Brew B, Sidtis J, Rosenblum M, Schenk AC & Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
15. Shirasaka T, Murakami K, Ford Jr H, Kelley JA, Yoshioka H, Kojima E, Aoki S, Broder S & Mitsuya H (1990) Lipophilic halogenated congeners of 2′,3′-dideoxypurine nucleosides active against human immunodeficiency virus in vitro. Proceedings of the National Academy of Sciences, USA 87:9426-9430.
16. Shirasaka T, Watanabe K, Yoshioka H, Kojima E, Aoki S, Murakami K & Mitsuya H (1991) Lipophilic 6-halo-2′, 3′-dideoxypurine nucleosides: potential antiretroviral agents targeting HIV-associated neurologic disorders. In Advances in Molecular Biology and Targeted Treatment for AIDS, pp. 323-333. Edited by A Kumar. New York: Plenum Press.
17. Tsai C-C, Follis KE, Grant R, Sabo A, Nolte R, Bartz C, Bischofberger N & Benveniste R (1994a) Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques. Journal of Medical Primatology 23:175-183.
18. Tsai C-C, Follis KE, Sabo A, Grant RF, Bartz C, Nolte RE, Benveniste RE & Bischofberger N (1994b) Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl) adenine against simian immunodeficiency virus infection in macaques. Journal of Infectious Diseases 169:260-266.
19. Tsai C-C, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE and Black R (1995) Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 270:1197-1199.